Everest Medicines Limited (1952.HK) - Quarterly Income Statement

Home
1952.HK
Financials

33.3 (HKD) • At close November 5, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q1
Revenue Numbers are in millions	150.759	150.759	58.519	58.519	4.448	4.448	5.874	5.874	0.522	0.522	0.027	0.027	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	35.219	35.219	15.548	15.548	1.659	1.659	2.141	2.141	0.182	0.182	0.012	0.012	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	115.54	115.54	42.971	42.971	2.789	2.789	3.734	3.734	0.34	0.34	0.016	0.016	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0.766	0.766	0.734	0.734	0.627	0.627	0.636	0.636	0.651	0.651	0.574	0.574	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	126.58	126.58	125.783	125.783	144.244	144.244	232.112	232.112	172.756	172.756	181.33	181.33	125.387	125.387	108.193	108.193	80.841	80.184	22.808
General & Administrative Expenses Numbers are in millions	43.499	43.499	40.732	40.732	41.233	41.233	78.463	78.463	59.173	59.173	66.914	66.914	52.342	52.342	88.045	88.045	78.614	22.702	3.645
Selling & Marketing Expenses Numbers are in millions	100.195	100.195	83.646	83.646	32.064	32.064	89.264	89.264	74.08	74.08	78.026	78.026	21.049	21.049	12.043	12.043	6.36	2.8	0
SG&A Numbers are in millions	143.694	143.694	124.657	124.657	73.631	73.631	168.083	168.083	133.535	133.535	145.65	145.65	74.763	74.763	100.302	100.302	84.974	25.502	3.645
Other Expenses Numbers are in millions	181.145	181.145	19.437	0	0	0	0	0	0	0	0	0	0	0	0	0	-46.163	45.22	3.412
Operating Expenses Numbers are in millions	451.418	451.418	269.877	271.103	239.192	239.192	195.674	195.674	339.828	339.828	327.263	327.263	189.15	189.15	2,510.142	2,510.142	119.652	150.906	29.865
Operating Income Numbers are in millions	-335.879	-335.879	-226.906	-211.736	-213.898	-213.898	-396.922	-396.922	-305.431	-305.431	-325.517	-325.517	-199.119	-199.119	-208.426	-208.426	-119.763	304.589	99.532
Operating Income Ratio Numbers are in millions	-2.228	-2.228	-3.878	-3.618	-48.094	-48.094	-67.573	-67.573	-585.117	-585.117	-12,056.185	-12,056.185	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	19.672	19.672	16.481	1.31	2.092	2.092	607.305	607.305	-28.59	-28.59	12.712	12.712	7.565	7.565	-2,308.892	-2,308.892	-807.727	-0.63	-0.409
Income Before Tax Numbers are in millions	-316.207	-316.207	-210.426	-210.426	-211.806	-211.806	210.384	210.384	-334.021	-334.021	-312.806	-312.806	-191.554	-191.554	-2,517.317	-2,517.317	-927.49	303.959	99.123
Income Before Tax Ratio Numbers are in millions	-2.097	-2.097	-3.596	-3.596	-47.624	-47.624	35.816	35.816	-639.887	-639.887	-11,585.389	-11,585.389	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	15.171	0	-0	0	0.004	0.004	0	0	0	0	0	0	0	0	7.071	0.63	0.409
Net Income Numbers are in millions	-316.207	-316.207	-210.426	-210.426	-211.806	-211.806	210.38	210.38	-334.021	-334.021	-312.806	-312.806	-191.554	-191.554	-2,517.317	-2,517.317	-934.561	303.959	99.123
Net Income Ratio Numbers are in millions	-2.097	-2.097	-3.596	-3.596	-47.624	-47.624	35.815	35.815	-639.887	-639.887	-11,585.389	-11,585.389	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.98	-0.98	-0.65	-0.65	-0.7	-0.7	0.7	0.7	-1.13	-1.13	-1.07	-1.07	-0.65	-0.65	-17.26	-11.72	-3.29	1.07	0.35
EPS Diluted Numbers are in millions	-0.98	-0.98	-0.65	-0.65	-0.7	-0.7	0.7	0.7	-1.13	-1.13	-1.07	-1.07	-0.65	-0.65	-17.26	-11.72	-3.29	1.07	0.35
EBITDA Numbers are in millions	-324.273	-324.273	-198.785	-198.785	-203.637	-203.637	-393.404	-393.404	-302.043	-302.043	-323.851	-323.851	-197.681	-197.681	-207.253	-207.253	-913.715	307.773	101.321
EBITDA Ratio Numbers are in millions	-2.151	-2.151	-3.397	-3.397	-45.787	-45.787	-66.974	-66.974	-578.626	-578.626	-11,994.463	-11,994.463	0	0	0	0	0	0	0

Everest Medicines Limited

HKEX:1952.HK Add to watchlist

HKEX:1952.HK